The Bioactive Materials Market is estimated to be valued at US$ 2,204.6 Mn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Bioactive materials are materials that interact with living tissue. They include glasses, ceramics and composite materials that bond to living bone or stimulate bone growth when implanted in the body. They are used in applications like orthopedic implants, tissue engineering and dental implants owing to their advantages like biocompatibility, non-toxicity and ability to bond with living tissues.
Market key trends:
One of the key trends in the bioactive materials market is technological advancements. Manufacturers are focusing on developing advanced bioactive materials with improved properties. For instance, materials are being developed that can stimulate specific cellular responses, promote tissue growth and integrate better with living tissues.Nanotechnology is also being applied to engineer bioactive materials at nano-scale level in order to mimic natural bone structure and response. 3D printing technologies are also enabling development of personalized bioactive materials tailored as per specific patient's need. With ongoing R&D, bioactive materials with augmented osteoconductivity, osteoinductivity and osteointegrative properties are expected to enter the market in coming years.
Porter’s Analysis
Threat of new entrants: The bioactive materials market requires significant R&D investments. This acts as a barrier for new companies to enter the market.
Bargaining power of buyers: Individual consumers have low bargaining power due to the specialized and highly technical nature of bioactive materials. However, large hospitals and healthcare organizations have moderate bargaining power.
Bargaining power of suppliers: A few large companies dominate the raw material supply landscape in this market. However, availability of substitutes provides some bargaining power to buyers.
Threat of new substitutes: Ongoing R&D in the development of novel biomaterials poses potential threats of new substitutes.
Competitive rivalry: The market is highly competitive with technology and innovation being the main competitive factors.
SWOT Analysis
Strengths: Bioactive materials have applications in various therapies like tissue engineering, drug delivery and wound healing due to their bio-compatibility and bonding abilities.
Weaknesses: High costs involved in R&D, regulatory approvals and manufacturing. Limited clinical evidence for long term efficacy and safety of some newer bioactive materials.
Opportunities: Growing geriatric population and subsequent rise in chronic diseases & injuries have increased the demand. Increasing healthcare investments and promotion of medical tourism in emerging nations.
Threats: Stringent regulatory framework and lengthy approval process. Reimbursement issues related to high costs of procedures involving bioactive materials. Competition from alternative treatments.
Key Takeaways
The global bioactive materials market is expected to witness high growth at a CAGR of 14% over the forecast period, due to increasing prevalence of musculoskeletal disorders, trauma injuries and dental diseases.
Regionally, North America accounted for the largest share of the global market in 2023. However, Asia Pacific is expected to witness the highest growth during the forecast period owing to rising healthcare expenditure, rapidly growing economy and increasing guidelines to promote medical tourism in countries like India and Thailand.
Key players operating in the bioactive materials market include Arthrex Inc, DePuy Synthes, Zimmer Biomet, Stryker Corporation, Medtronic and DSM. These players are focusing on developing innovative products with enhanced properties and broader applications. They are also collaborating with research institutes to strengthen their R&D capabilities.
Comments
0 comment